Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shandong Weigao Orthopaedic Device Co's quarterly Beginning Cash Position
declined
from Dec. 2025 (¥1,489 Mil) to Mar. 2026 (¥1,246 Mil) but then
increased
from Mar. 2026 (¥1,246 Mil) to Jun. 2026 (¥1,315 Mil).
Shandong Weigao Orthopaedic Device Co's annual Beginning Cash Position
declined
from Dec. 2023 (¥2,705 Mil) to Dec. 2024 (¥1,819 Mil) and
declined
from Dec. 2024 (¥1,819 Mil) to Dec. 2025 (¥1,690 Mil).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Weigao Orthopaedic Device Co Beginning Cash Position Chart
What does a Beginning Cash Position of ¥1,315 Mil mean?
Shandong Weigao Orthopaedic Device Co (SHSE:688161) has a Beginning Cash Position of ¥1,315 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Shandong Weigao Orthopaedic Device Co and its competitors.
Is Shandong Weigao Orthopaedic Device Co's Beginning Cash Position too high?
Shandong Weigao Orthopaedic Device Co's current Beginning Cash Position is ¥1,315 Mil. Overall, Shandong Weigao Orthopaedic Device Co has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Weigao Orthopaedic Device Co's Beginning Cash Position compare to ABT and SYK?
Shandong Weigao Orthopaedic Device Co's Beginning Cash Position of ¥1,315 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Devices & Instruments company?
A good Beginning Cash Position depends on the Medical Devices & Instruments industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Shandong Weigao Orthopaedic Device Co and its competitors. Shandong Weigao Orthopaedic Device Co's current Beginning Cash Position is ¥1,315 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Weigao Orthopaedic Device Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Weigao Orthopaedic Device Co (SHSE:688161) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥32.99, compared to a current price of ¥22.09 — trading 33% below its estimated fair value. The current Beginning Cash Position is ¥1,315 Mil. Shandong Weigao Orthopaedic Device Co's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Shandong Weigao Orthopaedic Device Co (SHSE:688161), the current Beginning Cash Position is ¥1,315 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Weigao Orthopaedic Device Co (SHSE:688161) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Weigao Orthopaedic Device Co stock appears to be undervalued.
The current stock price of ¥22.09 is trading 33% below its estimated GF Value™ of ¥32.99.
GuruFocus considers Shandong Weigao Orthopaedic Device Co to be Significantly Undervalued.
Key valuation signals for SHSE:688161:
Beginning Cash Position: ¥1,315 Mil
GF Value™: ¥32.99 vs. price of ¥22.09 (33% below fair value)
No single metric tells the full story. See the SHSE:688161 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688161 has been successfully added to your 
